Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

8.810 -0.750 (-7.85%)

Delayed Quote Updated: 9:38 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

August 18, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

August 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Stocks That Could Turn $1,000 Into $5,000 by 2030 ↗

August 09, 2025

All three of these companies are entering a period of what could produce unparalleled top- and bottom-line growth.

Via The Motley Fool

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Why Iovance Biotherapeutics Stock Plummeted Today ↗

August 08, 2025

The company's top line nearly doubled.

Via The Motley Fool

What 7 Analyst Ratings Have To Say About Iovance Biotherapeutics ↗

August 08, 2025

Via Benzinga

Pinterest Posts Downbeat Q2 Earnings, Joins Twilio, Trade Desk And Other Big Stocks Moving Lower In Friday Pre-Market Session ↗

August 08, 2025

Via Benzinga

Which stocks are moving before the opening bell on Friday? ↗

August 08, 2025

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 08, 2025

Via Benzinga

Iovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening ↗

August 08, 2025

Iovance stock fell over 29% pre-market after Q2 results, despite reporting a strong revenue jump led by Amtagvi sales.

Via Benzinga

Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 07, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

August 07, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Iovance (IOVA) Q2 Revenue Jumps 93% ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

August 07, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Is Iovance Biotherapeutics Stock Due for a Big Rally? ↗

July 30, 2025

The biotech stock has been picking up steam of late -- but will it last?

Via The Motley Fool

This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy? ↗

July 29, 2025

Even the average price estimate for this stock suggests it can soar, but not everyone's convinced.

Via The Motley Fool

Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025

July 24, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 24, 2025

Via Benzinga

Here are the top movers in Wednesday's session. ↗

July 23, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday ↗

July 23, 2025

Via Benzinga

These stocks are gapping in today's session ↗

July 23, 2025

The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Analyst Expectations For Iovance Biotherapeutics's Future ↗

July 23, 2025

Via Benzinga

Health In Tech (NASDAQ: HIT) Posts Blowout Q2, Stock Responds – HIT, SNYR, PNPN.V/PNPNF in Breakout Zone; See More to Watch Inside

July 22, 2025

Via AB Newswire

Topics Artificial Intelligence

Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock ↗

July 22, 2025

The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment.

Via Investor's Business Daily

D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday ↗

July 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

This Healthcare Stock Just Hit a 52-Week Low -- but Wall Street Sees 380% Upside ↗

July 21, 2025

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

July 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.